SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Raised by Institute for Wealth Management LLC.

Institute for Wealth Management LLC. lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 9,490 shares of the exchange traded fund’s stock after acquiring an additional 441 shares during the quarter. Institute for Wealth Management LLC.’s holdings in SPDR S&P Biotech ETF were worth $855,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the company. Oak Harvest Investment Services purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $2,633,000. Calton & Associates Inc. acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $494,000. OLD National Bancorp IN acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $450,000. Highland Capital Management LLC increased its stake in SPDR S&P Biotech ETF by 10.4% in the 4th quarter. Highland Capital Management LLC now owns 25,509 shares of the exchange traded fund’s stock valued at $2,297,000 after buying an additional 2,404 shares during the period. Finally, Ibex Wealth Advisors acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $1,473,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $92.67 on Friday. The firm has a market cap of $7.06 billion, a PE ratio of 11.47 and a beta of 1.11. The firm’s 50 day moving average price is $93.24 and its two-hundred day moving average price is $96.72. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.